198 related articles for article (PubMed ID: 28799813)
1. Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients.
Tas F; Erturk K
Cancer Invest; 2017 Sep; 35(8):501-505. PubMed ID: 28799813
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
3. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
Grotz TE; Vaince F; Hieken TJ
Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
[TBL] [Abstract][Full Text] [Related]
6. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.
Mihm MC; Clemente CG; Cascinelli N
Lab Invest; 1996 Jan; 74(1):43-7. PubMed ID: 8569196
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 expression in tumour-infiltrating lymphocytes is a poor prognostic factor for primary acral melanoma patients.
Ren M; Dai B; Kong YY; Lv JJ; Cai X
Histopathology; 2018 Sep; 73(3):386-396. PubMed ID: 29637587
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Melanoma Using Pathologic Features Identified by Natural Language Processing.
Yang J; Lian JW; Chin YH; Wang L; Lian A; Murphy GF; Zhou L
JAMA Netw Open; 2021 Sep; 4(9):e2126337. PubMed ID: 34550383
[TBL] [Abstract][Full Text] [Related]
10. Histological regression in melanoma: impact on sentinel lymph node status and survival.
Aivazian K; Ahmed T; El Sharouni MA; Stretch JR; Saw RPM; Spillane AJ; Shannon KF; Ch'ng S; Nieweg OE; Thompson JF; Lo SN; Scolyer RA
Mod Pathol; 2021 Nov; 34(11):1999-2008. PubMed ID: 34247192
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
Sinnamon AJ; Sharon CE; Song Y; Neuwirth MG; Elder DE; Xu X; Chu EY; Ming ME; Fraker DL; Gimotty PA; Karakousis GC
J Am Acad Dermatol; 2018 Aug; 79(2):245-251. PubMed ID: 29518458
[TBL] [Abstract][Full Text] [Related]
12. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.
Fortes C; Mastroeni S; Caggiati A; Passarelli F; Ricci F; Michelozzi P
Arch Dermatol Res; 2021 Jan; 313(1):57-61. PubMed ID: 32266533
[TBL] [Abstract][Full Text] [Related]
13. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
14. The value of tumor infiltrating lymphocytes as prognostic factor for lymph node status and survival amongst patients with cutaneous malignant melanoma.
Alexandru Gata V; Milan Kubelac P; Buiga R; Vlad IC; Valean D; Muntean MV; Morariu DS; Bonci EA; Irimie A; Dina C; Achimas Cadariu PA
J BUON; 2020; 25(6):2700-2707. PubMed ID: 33455116
[TBL] [Abstract][Full Text] [Related]
15. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma.
Tas F; Erturk K
Int J Dermatol; 2017 Feb; 56(2):166-170. PubMed ID: 27778319
[TBL] [Abstract][Full Text] [Related]
16. Anemia in Cutaneous Malignant Melanoma: Low Blood Hemoglobin Level is Associated with Nodal Involvement, Metastatic Disease, and Worse Survival.
Tas F; Erturk K
Nutr Cancer; 2018; 70(2):236-240. PubMed ID: 29267010
[TBL] [Abstract][Full Text] [Related]
17. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.
Tas F; Erturk K
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2721-2729. PubMed ID: 33611652
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
20. Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients.
Donizy P; Kaczorowski M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Anticancer Res; 2015 Jan; 35(1):351-8. PubMed ID: 25550571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]